CA2491118A1 - A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof - Google Patents

A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof Download PDF

Info

Publication number
CA2491118A1
CA2491118A1 CA002491118A CA2491118A CA2491118A1 CA 2491118 A1 CA2491118 A1 CA 2491118A1 CA 002491118 A CA002491118 A CA 002491118A CA 2491118 A CA2491118 A CA 2491118A CA 2491118 A1 CA2491118 A1 CA 2491118A1
Authority
CA
Canada
Prior art keywords
salt
omeprazole
organic
mixture
esomeprazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002491118A
Other languages
English (en)
French (fr)
Inventor
Manne Satyanarayana Reddy
Muppa Kishore Kumar
Kikkuru Srirami Reddy
Koilkonda Purandhar
Keshaboina Sreenath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2003/020250 external-priority patent/WO2004002982A2/en
Publication of CA2491118A1 publication Critical patent/CA2491118A1/en
Abandoned legal-status Critical Current

Links

CA002491118A 2002-06-27 2003-06-27 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof Abandoned CA2491118A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN489/MAS/2002 2002-06-27
IN489MA2002 2002-06-27
IN493/MAS/2002 2002-06-28
IN493MA2002 2002-06-28
PCT/US2003/020250 WO2004002982A2 (en) 2002-06-27 2003-06-27 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof

Publications (1)

Publication Number Publication Date
CA2491118A1 true CA2491118A1 (en) 2004-01-08

Family

ID=34276871

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002491118A Abandoned CA2491118A1 (en) 2002-06-27 2003-06-27 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof

Country Status (5)

Country Link
CN (1) CN100378093C (zh)
AT (1) ATE353887T1 (zh)
AU (1) AU2003247729B2 (zh)
CA (1) CA2491118A1 (zh)
DE (1) DE60311809T2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143722A1 (en) * 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
CN103145694B (zh) * 2011-12-06 2016-01-20 重庆煜澍丰医药有限公司 埃索美拉唑钠盐的晶体r及其制备方法和用途
CN102993184A (zh) * 2013-01-08 2013-03-27 湖南方盛制药股份有限公司 一种埃索美拉唑及其镁盐三水合物的制备方法
CN103664887B (zh) * 2013-12-18 2015-09-16 成都医路康医学技术服务有限公司 埃索美拉唑钠的制备方法
CN104530003A (zh) * 2014-06-10 2015-04-22 广东东阳光药业有限公司 吡啶甲基亚磺酰基-1h-苯并咪唑类化合物的盐的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Also Published As

Publication number Publication date
DE60311809D1 (de) 2007-03-29
AU2003247729A1 (en) 2004-01-19
DE60311809T2 (de) 2007-11-22
ATE353887T1 (de) 2007-03-15
CN100378093C (zh) 2008-04-02
CN1665805A (zh) 2005-09-07
AU2003247729B2 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
EP1515963B1 (en) A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
AU2006222032B2 (en) Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-Binaphthalene-2, 2'diol
CA2226184C (en) A process for the optical purification of enantiomerically enriched benzimidazole derivatives
AU2007257171B2 (en) A novel process for the preparation of esomeprazole and salts thereof
KR101062806B1 (ko) 광학적으로 순수한 활성 화합물의 제조 방법
RU2345075C2 (ru) Способ получения фармацевтических средств и соединения, полученные данным способом
WO2006040635A1 (en) Processes for the preparation of substituted sulfoxides
KR101169471B1 (ko) (ｓ)-판토프라졸의 제조 방법
US8420822B2 (en) Optical resolution of substituted 2-(2-pyridinylmethylsulphinyl)-1H-benzimidazoles
AU2003247729B2 (en) A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
EP1465890A1 (en) Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued